CSPC Pharmaceutical Group Limited (CSPCY)

USD 2.34

(0.43%)

Inventory Summary of CSPC Pharmaceutical Group Limited

CSPC Pharmaceutical Group Limited's latest annual inventory in 2023 was 3.13 Billion CNY , up 22.85% from previous year.
CSPC Pharmaceutical Group Limited's latest quarterly inventory in 2023 FY was 3.13 Billion CNY , up 22.85% from previous quarter.
CSPC Pharmaceutical Group Limited reported annual inventory of 2.55 Billion CNY in 2022, up 3.0% from previous year.
CSPC Pharmaceutical Group Limited reported annual inventory of 2.48 Billion CNY in 2021, up 33.28% from previous year.
CSPC Pharmaceutical Group Limited reported quarterly inventory of - CNY for 2023 Q1, down -100.0% from previous quarter.
CSPC Pharmaceutical Group Limited reported quarterly inventory of 2.75 Billion CNY for 2023 Q2, down 0.0% from previous quarter.

Annual Inventory Chart of CSPC Pharmaceutical Group Limited (2023 - 2003)

Historical Annual Inventory of CSPC Pharmaceutical Group Limited (2023 - 2003)

Year	Inventory	Inventory Growth
2023	3.13 Billion CNY	22.85%
2022	2.55 Billion CNY	3.0%
2021	2.48 Billion CNY	33.28%
2020	1.86 Billion CNY	-26.61%
2019	2.53 Billion CNY	-16.57%
2018	3.03 Billion HKD	25.39%
2017	2.42 Billion HKD	40.03%
2016	1.73 Billion HKD	13.63%
2015	1.52 Billion HKD	5.5%
2014	1.44 Billion HKD	-0.39%
2013	1.44 Billion HKD	-10.98%
2012	1.62 Billion HKD	22.61%
2011	1.32 Billion HKD	29.35%
2010	1.02 Billion HKD	19.18%
2009	861.54 Million HKD	-26.14%
2008	1.16 Billion HKD	0.0%
2007	- HKD	-100.0%
2006	684.77 Million HKD	-12.99%
2005	787 Million HKD	63.12%
2004	482.47 Million HKD	55.04%
2003	311.18 Million HKD	0.0%

Year	Inventory	Inventory Growth
2023 FY	3.13 Billion CNY	22.85%
2023 Q1	- CNY	-100.0%
2023 Q2	2.75 Billion CNY	0.0%
2023 Q3	- CNY	-100.0%
2023 Q4	3.13 Billion CNY	0.0%
2022 Q2	2.62 Billion CNY	0.0%
2022 Q4	2.55 Billion CNY	0.0%
2022 FY	2.55 Billion CNY	3.0%
2021 Q4	2.48 Billion CNY	0.0%
2021 FY	2.48 Billion CNY	33.28%
2021 Q2	1.83 Billion CNY	0.0%
2020 FY	1.86 Billion CNY	-26.61%
2020 Q2	2.1 Billion CNY	0.0%
2020 Q4	1.86 Billion CNY	0.0%
2019 Q2	2.47 Billion CNY	0.0%
2019 FY	2.53 Billion CNY	-16.57%
2019 Q4	2.53 Billion CNY	0.0%
2018 Q2	2.72 Billion HKD	0.0%
2018 FY	3.03 Billion HKD	25.39%
2018 Q4	3.03 Billion HKD	0.0%
2017 Q4	2.42 Billion HKD	0.0%
2017 Q2	2.2 Billion HKD	0.0%
2017 FY	2.42 Billion HKD	40.03%
2016 FY	1.73 Billion HKD	13.63%
2016 Q2	1.66 Billion HKD	0.0%
2016 Q4	1.73 Billion HKD	0.0%
2015 Q4	1.52 Billion HKD	0.0%
2015 Q2	1.74 Billion HKD	0.0%
2015 FY	1.52 Billion HKD	5.5%
2014 FY	1.44 Billion HKD	-0.39%
2014 Q4	1.44 Billion HKD	0.0%
2014 Q2	1.63 Billion HKD	0.0%
2013 Q2	1.61 Billion HKD	0.0%
2013 Q4	1.44 Billion HKD	0.0%
2013 FY	1.44 Billion HKD	-10.98%
2012 FY	1.62 Billion HKD	22.61%
2012 Q4	1.62 Billion HKD	0.0%
2012 Q2	1.21 Billion HKD	0.0%
2011 FY	1.32 Billion HKD	29.35%
2011 Q2	1.21 Billion HKD	0.0%
2011 Q4	1.32 Billion HKD	0.0%
2010 Q4	1.02 Billion HKD	0.0%
2010 FY	1.02 Billion HKD	19.18%
2010 Q2	1 Billion HKD	0.0%
2009 Q4	861.54 Million HKD	0.0%
2009 FY	861.54 Million HKD	-26.14%
2008 FY	1.16 Billion HKD	0.0%
2007 FY	- HKD	-100.0%
2006 FY	684.77 Million HKD	-12.99%
2005 FY	787 Million HKD	63.12%
2004 FY	482.47 Million HKD	55.04%
2003 FY	311.18 Million HKD	0.0%

Peer Inventory Comparison of CSPC Pharmaceutical Group Limited

Name	Inventory	Inventory Difference
AstraZeneca PLC	5.41 Billion USD	42.052%
Bristol-Myers Squibb Company PFD CONV 2	2.66 Billion USD	-17.906%
CSPC Pharmaceutical Group Limited	442.43 Million USD	-609.412%
Clarus Therapeutics Holdings, Inc.	14.21 Million USD	-21981.497%
Novartis AG	5.91 Billion USD	46.919%
PT Kalbe Farma Tbk.	451.27 Million USD	-595.503%